LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 1476 | 3967 | 3788 | 1.0471 | 1.0688 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 1476 | 4271 | 3731 | 1.1447 | 1.2126 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 1476 | 4377 | 3796 | 1.1529 | 1.2201 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 1476 | 3942 | 3788 | 1.0405 | 1.0592 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 1476 | 4143 | 3731 | 1.1104 | 1.1629 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 1476 | 4183 | 3796 | 1.1018 | 1.1475 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 1476 | 3944 | 3788 | 1.0410 | 1.0600 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 1476 | 4049 | 3731 | 1.0852 | 1.1261 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 1476 | 4066 | 3796 | 1.0709 | 1.1032 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 1476 | 4060 | 3788 | 1.0716 | 1.1044 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 1476 | 4091 | 3731 | 1.0964 | 1.1425 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 1476 | 4012 | 3796 | 1.0567 | 1.0827 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 1476 | 4004 | 3788 | 1.0568 | 1.0830 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 1476 | 3728 | 3731 | 0.9991 | 0.9987 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 1476 | 1895 | 3796 | 0.4991 | 0.2009 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 1476 | 3496 | 3413 | 1.0242 | 1.0400 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 1476 | 3410 | 3783 | 0.9013 | 0.8526 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 1476 | 3554 | 3734 | 0.9518 | 0.9275 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 1476 | 2893 | 3413 | 0.8476 | 0.7443 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 1476 | 3132 | 3783 | 0.8278 | 0.7401 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 1476 | 2968 | 3734 | 0.7948 | 0.6847 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1476 | 2937 | 3413 | 0.8605 | 0.7662 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1476 | 2804 | 3783 | 0.7411 | 0.6039 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1476 | 2841 | 3734 | 0.7608 | 0.6305 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 1 | E15 | 72 | hr | 1476 | 2491 | 3413 | 0.7298 | 0.5412 |